What is I3LUNG
I3LUNG is a European project funded under the framework of the Horizon Europe (HEurope) call “Ensuring access to innovative, sustainable and high-quality health care”. Our consortium gathers 16 partners with different expertise located worldwide, with the common goal of providing better assistance and individualize treatment for patients affected by metastatic lung cancer.
For Patients
In the video below the project explained by Anne-Marie Baird, President of Lung Cancer Europe (LuCE) (one of the partners of the I3LUNG).
“We are excited to start this project which is envisioned to both generate novel therapeutic guidelines for clinical practice in lung cancer and support the growth of digital diagnostic tools in the European industry. (I3LUNG Partners)„
Find out the most relevant news on the latest advancements in lung cancer!
News
July, 16 2025
🔊 A cough might reveal more than we think… Yesterday at #EMBC 2025 in Copenhagen, Chiara Giangregorio (Politecnico di Milano) […]
News
July, 8 2025
In this video, Anniina Hentinen from Lung Cancer Europe breaks down what AI really means for patients: 🧠 AI analyzes […]
News
July, 3 2025
Chiara Giangregorio decodes data patterns. Valeria Sebri brings in the psychological layer. Together, they turn raw data into insights that […]